Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-15

FDA Approved: EMTRICITABINE — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved the original application for emtricitabine from Aurobindo Pharma Limited (ANDA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Emtricitabine (Emtricitabine)

Snippet

ORIG AP for EMTRICITABINE (EMTRICITABINE)